Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence X Yu

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|January 11, 2008
Pharmaceutical quality by design: product and process development, understanding, and controlLawrence X Yu
International Journal of Pharmaceutics|June 2, 2015
FDA pharmaceutical quality oversightLawrence X Yu, Janet Woodcock
International Journal of Pharmaceutics|June 17, 2017
The future of pharmaceutical quality and the path to get thereLawrence X Yu, Michael Kopcha
JAMA Internal Medicine|January 2, 2013
Generic pills from the patient perspective: dressed for success?Lawrence X Yu, Gregory P Geba
Bioanalysis|February 16, 2011
In vitro and in vivo characterizations of PEGylated liposomal doxorubicinWenlei Jiang, Robert Lionberger, Lawrence X Yu
AAPS Pharmscitech|May 3, 2013
Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprintHaoshu Xiong, Lawrence X Yu, Haibin Qu
The New England Journal of Medicine|December 11, 2012
Withdrawal of generic budeprion for nonbioequivalenceJanet Woodcock, Mansoor Khan, Lawrence X Yu
The AAPS Journal|April 22, 2009
Mechanistic approaches to predicting oral drug absorptionWeili Huang, Sau Lawrence Lee, Lawrence X Yu
Pharmaceutical Research|March 10, 2011
Pharmaceutical equivalence by design for generic drugs: modified-release productsAndré Sirota Raw, Robert Lionberger, Lawrence X Yu
Molecular Pharmaceutics|July 21, 2005
Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substratesHyojong Kwon, Robert A Lionberger, Lawrence X Yu
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|January 11, 2008
Pharmaceutical quality by design: product and process development, understanding, and controlLawrence X Yu
International Journal of Pharmaceutics|June 2, 2015
FDA pharmaceutical quality oversightLawrence X Yu, Janet Woodcock
International Journal of Pharmaceutics|June 17, 2017
The future of pharmaceutical quality and the path to get thereLawrence X Yu, Michael Kopcha
JAMA Internal Medicine|January 2, 2013
Generic pills from the patient perspective: dressed for success?Lawrence X Yu, Gregory P Geba
Bioanalysis|February 16, 2011
In vitro and in vivo characterizations of PEGylated liposomal doxorubicinWenlei Jiang, Robert Lionberger, Lawrence X Yu
AAPS Pharmscitech|May 3, 2013
Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprintHaoshu Xiong, Lawrence X Yu, Haibin Qu
The New England Journal of Medicine|December 11, 2012
Withdrawal of generic budeprion for nonbioequivalenceJanet Woodcock, Mansoor Khan, Lawrence X Yu
The AAPS Journal|April 22, 2009
Mechanistic approaches to predicting oral drug absorptionWeili Huang, Sau Lawrence Lee, Lawrence X Yu
Pharmaceutical Research|March 10, 2011
Pharmaceutical equivalence by design for generic drugs: modified-release productsAndré Sirota Raw, Robert Lionberger, Lawrence X Yu
Molecular Pharmaceutics|July 21, 2005
Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substratesHyojong Kwon, Robert A Lionberger, Lawrence X Yu
Pageof 8